Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3214-9.
View in:
PubMed
subject areas
Animals
Anti-Mullerian Hormone
Cell Transplantation
CHO Cells
Cricetinae
Female
Glycoproteins
Growth Inhibitors
Humans
Mice
Mice, SCID
Neoplasms, Experimental
Ovarian Neoplasms
Recombinant Fusion Proteins
Testicular Hormones
Tumor Cells, Cultured
authors with profiles
Antonia Elizabeth Stephen, M.D.
Peter T. Masiakos, M.D.
Patricia Donahoe, M.D.
Joseph Philip Vacanti, M.D.